Skip to content

Mobile Unit Screening of Pathologies Associated With Chronic Diseases - Feasibility

Mobile Unit Screening of Pathologies Associated With Chronic Diseases - Part I Feasibility

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02214056
Acronym
DéProPAss
Enrollment
27
Registered
2014-08-12
Start date
2015-02-28
Completion date
2015-04-30
Last updated
2015-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerosis, Chronic Obstructive Pulmonary Disease, Type II Diabetes

Keywords

mobile screening team, feasibility

Brief summary

The main objective of this study is to assess the feasibility of standardized screening for comorbidities among patients with one or more of three chronic diseases (diabetes, COPD, atherosclerosis) by a mobile unit at times and localities under-served by health actors.

Detailed description

The investigators secondary objectives include assessing patient and GP satisfaction in relation to the mobile screening team.

Interventions

Participating general practitioners (GPs) will inform and recruit participants from among regular patient consults. Using the provided web tools, GPs will organize a visit with the mobile team that fits the needs of the patient.

PROCEDUREMobile team exam

Each patient enrolled will receive a standardized assessment in one locality, made in about two hours, and comprising: questionnaire responses, a complete physical exam, a 12-lead ECG, spirometry before and after administration of β2-agonists, an arterial Doppler ultrasound (carotid and abdominal), ankle-brachial index (systolic pressure at the toe). At the end of two hours, each patient will evaluate their satisfaction using a survey of acceptability and leave with a full report to the attention of their general practitioner (copy sent to Physician if needed) detailing the results of the different examinations.

Sponsors

Centre Hospitalier Universitaire de Nīmes
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The patient must have given his/her informed and signed consent * The patient must be insured or beneficiary of a health insurance plan * The patient has one or more of the following three diseases: (1) chronic obstructive pulmonary disease (COPD); (2) type II diabetes; (3) atherosclerosis.

Exclusion criteria

* The patient is participating in another study * The patient is in an exclusion period determined by a previous study * The patient is under judicial protection, under tutorship or curatorship * The patient refuses to sign the consent * It is impossible to correctly inform the patient * There is a need to take urgent therapeutic care in the opinion of the general practitioner * The patient has received within the past year, a full examination including Doppler assessment of supra-aortic arteries, abdominal aorta and lower limbs; the patient has received a measure of the ankle-brachial index at the toe.

Design outcomes

Primary

MeasureTime frame
Percentage of eligible patients who actually received the mobile team examDay of mobile team exam (day 0)

Secondary

MeasureTime frameDescription
GP and patient acceptability of the mobile team examDay of mobile team exam (day 0)Visual analog scales (ranging from 0 to 10) for access, delays, organization and satisfaction.
Observance: percentage of patients included that actually received the balance sheetDay of mobile team exam (day 0)
Time in days between making the appointment by the general practitioner and the mobile team examDay of mobile team exam (day 0)
Percentage of mobile team exams in which one or more comorbidities was discoveredDay of mobile team exam (day 0)
Average time required for the patient to fill out questionnairesDay of mobile team exam (day 0)
Percentage of complete mobile team exams, that is to say in which all the data and all the variables have been collected and interpretedDay of mobile team exam (day 0)
Percentage of GPs who participated in the studyDay of mobile team exam (day 0)
Average per patient time necessary to carry out the mobile team examDay of mobile team exam (day 0)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026